Ametris (formerly ActiGraph)

📣 Our first Digital Health Monthly webinar of 2026 is less than a week away! Register now to join us for: Introducing 6M95C, A Novel Digital Measure for Tracking Disease Progression in Duchenne Muscular Dystrophy (DMD) #digitalmeasures #neuromuscular #DMD

Hey everyone 👋 Thank you for engaging with us on #wearable #digitalhealth topics over the years! However, this will be our last post on X.
Don’t worry, you can still engage with #Ametris (formerly #ActiGraph) on LinkedIn, Facebook & Bluesky - we’d love to stay connected! 🔗👇

💭 Are you interested to learn about the latest #DHT applications in clinical research? ❗Join us on September 12th at #ADDSBasel2025 for case studies, lessons learned, and best practices to accelerate the adoption of DHTs. View our agenda & register using the link ⤵️

📨 This is your invitation to join the next #DigitalHealthMonthly #Webinar - #DECODE #Obesity: Advancing Digital Endpoints for the Next Generation of Treatments
⤵️ Learn how this collaboration is shaping the future of obesity #clinicalresearch. Register using the link below!

📣 We are excited to announce our next #DECODE working group in Obesity! Led by #Ametris, DECODE #Obesity is a collaboration including initial pharma company partners Eli Lilly and Company, F. Hoffmann La Roche, & Novo Nordisk. Read the full announcement: hubs.la/Q03GtSYc0